Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study

Luisa Brussino, Maria Aliani, Elena Altieri, Pietro Bracciale, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Laura Malerba, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Gianenrico Senna, Alessandra Vultaggio, Maria D’Amato

Open source

DOI
10.3389/falgy.2025.1501196
Published
2025-03-20
Container
Frontiers in Allergy
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/falgy.2025.1501196,
  title = {Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study},
  author = {Luisa Brussino and Maria Aliani and Elena Altieri and Pietro Bracciale and Maria Filomena Caiaffa and Paolo Cameli and Giorgio Walter Canonica and Cristiano Caruso and Stefano Centanni and Fausto De Michele and Stefano Del Giacco and Fabiano Di Marco and Laura Malerba and Francesco Menzella and Girolamo Pelaia and Paola Rogliani and Micaela Romagnoli and Pietro Schino and Jan Walter Schroeder and Gianenrico Senna and Alessandra Vultaggio and Maria D’Amato},
  year = {2025},
  journal = {Frontiers in Allergy},
  doi = {10.3389/falgy.2025.1501196},
  url = {https://doi.org/10.3389/falgy.2025.1501196}
}

RIS

TY  - JOUR
TI  - Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
AU  - Luisa Brussino
AU  - Maria Aliani
AU  - Elena Altieri
AU  - Pietro Bracciale
AU  - Maria Filomena Caiaffa
AU  - Paolo Cameli
AU  - Giorgio Walter Canonica
AU  - Cristiano Caruso
AU  - Stefano Centanni
AU  - Fausto De Michele
AU  - Stefano Del Giacco
AU  - Fabiano Di Marco
AU  - Laura Malerba
AU  - Francesco Menzella
AU  - Girolamo Pelaia
AU  - Paola Rogliani
AU  - Micaela Romagnoli
AU  - Pietro Schino
AU  - Jan Walter Schroeder
AU  - Gianenrico Senna
AU  - Alessandra Vultaggio
AU  - Maria D’Amato
PY  - 2025
JO  - Frontiers in Allergy
DO  - 10.3389/falgy.2025.1501196
UR  - https://doi.org/10.3389/falgy.2025.1501196
ER  - 

APA

Brussino, L., Aliani, M., Altieri, E., Bracciale, P., Caiaffa, M. F., Cameli, P., Canonica, G. W., Caruso, C., Centanni, S., Michele, F. D., Giacco, S. D., Marco, F. D., Malerba, L., Menzella, F., Pelaia, G., Rogliani, P., Romagnoli, M., Schino, P., Schroeder, J. W., Senna, G., Vultaggio, A., & D’Amato, M. (2025). Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study. Frontiers in Allergy. https://doi.org/10.3389/falgy.2025.1501196

Source records